Generics

Filter

Current filters:

None

Popular Filters

3 to 27 of 1196 results

Chinese heparin API market to account for about 80% of global demand; report

Chinese heparin API market to account for about 80% of global demand; report

21-10-2014

It is projected that the heparin active pharmaceutical ingredient (API) in China will achieve an additional…

Cardio-vascularChinaGenericsMarkets & Marketing

Valeant third-qtr profits beat expectations

20-10-2014

Canadian drugmaker Valeant Pharmaceuticals International has posted third-quarter 2014 financial results…

AllerganFinancialGenericsMergers & AcquisitionsValeant Pharmaceuticals International

New report: The myth of high Danish medicine prices

20-10-2014

The price-cap agreements between Lif, the Danish pharmaceutical industry group, and the government help…

DenmarkGenericsPharmaceuticalPricing

Actavis challenges Quillivant XR patent

16-10-2014

Ireland-headquartered generics major Actavis confirmed that it has filed an Abbreviated New Drug Application…

ActavisGenericsLegalNeurologicalPatentsPfizerQuillivantRegulationTris PharmaUSA

Teva’s Copaxone case heard again by US Supreme Court

Teva’s Copaxone case heard again by US Supreme Court

16-10-2014

The patent battle over Israel-based Teva Pharmaceutical Industries’ multiple sclerosis drug Copaxone…

CopaxoneGenericsLaw CrimeLegalMylanNeurologicalTevaUS Supreme CourtUSA

FDA consent decree with Ascend Labs backed by federal judge

FDA consent decree with Ascend Labs backed by federal judge

15-10-2014

A federal judge from the US District Court for the Southern District of Ohio entered a consent decree…

Ascend LaboratoriesGenericsLegalProductionRegulationUSA

Netherlands Pharma market growth held back by govt generics policy

14-10-2014

The Netherlands’ pharmaceutical market value will rise slowly from around $6.7 billion in 2014 to $7.2…

FinancialGenericsHealthcareMarkets & MarketingNetherlands

Growth set to return to CIS by 2015 with Kazakhstan in the lead

Growth set to return to CIS by 2015 with Kazakhstan in the lead

13-10-2014

Growth is set to return to markets in the Commonwealth of Independent States between 2015 and 2019, according…

GenericsKazakhstanMarkets & MarketingPharmaceuticalRussiaUkraine

US Congressmen investigate “staggering price increases” for generic drugs

US Congressmen investigate “staggering price increases” for generic drugs

10-10-2014

Letters have been sent to 14 drug manufacturers, including several major Indian firms, requesting information…

GenericsPoliticsPricingUSA

Impax Labs goes on a $700 million buying spree

Impax Labs goes on a $700 million buying spree

09-10-2014

US generic drugmaker Impax Laboratories saw its shares leap 11.2% to $26.52 in pre-market trading today,…

Amedra PharmaceuticalsCorePharmaGenericsImpax LaboratoriesLineage TherapeuticsMergers & AcquisitionsTaiwanUSA

Cipla in deal with Teva for South African marketing

Cipla in deal with Teva for South African marketing

09-10-2014

Indian drugmaker Cipla has entered into a collaboration with Israel's Teva Pharmaceuticals Industries,…

CiplaGenericsMarkets & MarketingSouth AfricaTeva Pharmaceuticals Industries

Mylan debuts generic of ViiV’s Combivir in USA

Mylan debuts generic of ViiV’s Combivir in USA

06-10-2014

US generic drugmaker Mylan has launched of its Lamivudine and Zidovudine Tablets USP, 15mg/300mg, which…

Anti-viralsCombivirGenericsGlaxoSmithKlineMarkets & MarketingMylanUSAViiV Healthcare

Strides Arcolab and Shasun Pharma to merge

Strides Arcolab and Shasun Pharma to merge

03-10-2014

The boards of Indian drugmakers Strides Arcolab and Shasun Pharmaceuticals have approved a scheme of…

GenericsIndiaMergers & AcquisitionsShasun PharmaceuticalsStrides Arcolab

Supernus sues Actavis for Trokendi XR patents infringement

Supernus sues Actavis for Trokendi XR patents infringement

02-10-2014

USA-based specialty drug firm Supernus Pharmaceuticals says it has sued generic drugmaker Actavis and…

ActavisGenericsLegalNeurologicalPatentsSupernus PharmaceuticalsTrokendi XRUSA

Intrexon and Amneal in second product collaboration

Intrexon and Amneal in second product collaboration

02-10-2014

US synthetic biology specialist Intrexon and privately-held generics drugmaker Amneal Pharmaceuticals…

Amneal PharmaceuticalsGenericsIntrexonLicensingProductionUSA

Hospira warned by FDA over Australian manufacturing facility

Hospira warned by FDA over Australian manufacturing facility

02-10-2014

USA-based injectable generic drugs specialist Hospira revealed in a filing with the US Securities and…

AustraliaGenericsHospiraProductionRegulationUSA

Indian government takes action over dubious fixed-dose combinations

Indian government takes action over dubious fixed-dose combinations

30-09-2014

In a bid to weed out potentially unsafe combinations, the Central Drugs Standards and Control Organization…

Cadila PharmaGenericsIndiaPricingRegulation

Update: Negotiations on EU-Canada Free Trade Agreement concluded

Update: Negotiations on EU-Canada Free Trade Agreement concluded

29-09-2014

Canadian trade group Research-Based Pharmaceutical Companies (Rx&D) expressed its support to the government…

CanadaEuropeGenericsMarkets & MarketingPatentsPoliticsRegulation

Indian industry decries smear campaign against its pharma exporters

Indian industry decries smear campaign against its pharma exporters

26-09-2014

The India Brand Equity Foundation (IBEF), on behalf of the government of India, has taken strong objection…

Antibiotics and Infectious diseasesGenericsIndiaMarkets & MarketingPoliticsProductionUSA

Actavis files ANDA for generic of Purdue's Butrans

Actavis files ANDA for generic of Purdue's Butrans

26-09-2014

Ireland-headquartered generics major Actavis has filed an Abbreviated New Drug Application with the US…

ActavisAnalgesiaBuprenorphineButransGenericsLegalPurdue PharmaRegulationUSA

Generics maker IGI Laboratories acquires 18 AstraZeneca drugs

Generics maker IGI Laboratories acquires 18 AstraZeneca drugs

25-09-2014

New Jersey-based specialty generic company IGI Laboratories has acquired regulatory rights, related documents…

AstraZenecaGenericsIGI LaboratoriesLicensingUSA

3 to 27 of 1196 results

Back to top